VahatiCor Names Harry Rowland CEO

VahatiCor welcomes Harry Rowland, Ph.D., as Chief Executive Officer. Harry joins VahatiCor as the company advances the A-FLUX Reducer System for patients with Coronary Microvascular Dysfunction, enrolls SERRA-I, and prepares for SERRA-II. https://lnkd.in/e9ABkEfx "Harry is the right leader for VahatiCor at this pivotal stage, when breakthrough technology requires disciplined execution." — Brian Smith, Managing Director, S3 Ventures VahatiCor will attend #EuroPCR 2026 in Paris from May 19 to 22. The company will hold a scientific symposium on Wednesday, May 20, from 12:30 to 13:15 CEST in Room 241 at the Palais des Congrès. Welcome, Harry. #VahatiCor, #CMD, #MicrovascularDisease, #EuroPCR2026, #MedTech #leadership #interventionalcardiology #cardiology

When building a medtech company, you need the right science and the right leader. We've always believed in A-FLUX. Today, I'm confident we have both. Welcoming Harry Rowland as CEO of VahatiCor is a milestone I've been working toward for some time. Harry has led a company through this exact arc — from clinical concept to FDA approval to acquisition by a global cardiovascular leader. He knows what it takes to build the team, generate the evidence, and execute at every stage. That's precisely what VahatiCor needs right now. I look forward to continuing to work with Harry, our physician collaborators, investors, and the full VahatiCor team as a member of the Board of Directors while the company moves into this next phase. And the timing couldn't be better. We're heading to EuroPCR in Paris this week, where we'll be sharing early clinical evidence from our SERRA-I study. If you're there, join us on Wednesday, May 20, for our symposium: "Early Evidence from a Next-Generation Coronary Sinus Reducer for the Treatment of Coronary Microvascular Dysfunction." Exciting things ahead. Welcome, Harry. https://lnkd.in/dMnHCqwT

Happy to share our poster presented at ESTRO 2026 by my colleague Agathe Leroux. Our work focuses on the dosimetric evaluation and image quality assessment of corrected cone-beam CT (corrCBCT) for offline adaptive radiotherapy workflows. The results suggest that corrCBCT could be a promising alternative to re-scan CT for delivered dose assessment in clinical routine, with overall good dosimetric consistency. Many thanks to Jimmy Fontaine, Jean-Baptiste Guy and the whole team at the Centre Marie Curie Valence. #ESTRO2026 #AdaptiveRadiotherapy #MedicalPhysics #Radiotherapy #CBCT

NEW in JMIRO! From "Pie in the Sky" to a nationally significant research program: this new article chronicles the Australian MRI Linac Program, a 16-year effort that secured over $27 million in funding, produced more than 120 publications, and trained a new generation of researchers in MRI-guided radiotherapy. Read more: https://ow.ly/ZTWP50ZbAs7 #MRILinac #RadiotherapyResearch #MRIResearch #MedicalInnovation #RadiationOncology

𝗘𝘃𝗲𝗻𝘁 𝗮𝗻𝗰𝗵𝗼𝗿𝗲𝗱 𝗚𝗿𝗲𝗮𝘁 𝘁𝗵𝗶𝗻𝗴𝘀 𝗮𝗿𝗲 𝗵𝗮𝗽𝗽𝗲𝗻𝗶𝗻𝗴 𝗮𝘁 𝗘𝗦𝗧𝗥𝗢 𝟮𝟬𝟮𝟲. 𝗔𝗻𝗱 𝘄𝗲 𝗰𝗼𝘂𝗹𝗱 𝗻𝗼𝘁 𝗯𝗲 𝗺𝗼𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝗼𝗳 𝗼𝘂𝗿 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀. For over two decades, Meditronix Corporation has had the privilege of bringing Klarity Medical's solutions to radiation oncology centers across India. A partnership built on shared values of precision, patient safety, and clinical reliability. The 𝗞𝗹𝗮𝗿𝗶𝘁𝘆 𝗔𝗰𝗰𝘂𝗧𝗿𝗮𝗸 𝗦𝗚𝗥𝗧 𝗦𝘆𝘀𝘁𝗲𝗺, 𝘁𝗵𝗲𝗿𝗺𝗼𝗽𝗹𝗮𝘀𝘁𝗶𝗰 𝗺𝗮𝘀𝗸𝘀, 𝗔𝗹𝗹-𝗶𝗻-𝗢𝗻𝗲 𝗯𝗮𝘀𝗲 𝗽𝗹𝗮𝘁𝗲𝘀, 𝗮𝗻𝗱 𝗦𝗕𝗥𝗧 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 that are being showcased at Booth C15:61 in Vienna are the same systems we bring to radiation oncology centres across India, backed by local installation, training, and support. If you are at #ESTRO2026, visit the Klarity booth and experience these solutions firsthand. If you are in India and want to explore what Klarity can do for your department, we are right here. 🌐 meditronixcorporation.com #MeditronixCorporation #Klarity #RadiationOncology #SGRT #PatientPositioning #Radiotherapy #MedicalPhysics #IndiaHealthcare #HealthcareInfrastructure

Fast, focused and very much living up to the name. This afternoon’s Rapid Fire IO from Theory to Table session brought together a series of short, sharp lectures covering some major areas of interventional oncology. The session included ablation navigation and robotics, intra procedural margin confirmation, renal ablation techniques, TACE technologies, and complex biliary access and stents. A huge well done to everyone involved. These quick fire rounds were fast and furious, and keeping that level of pace, clarity and clinical insight is no easy task. #BSIR #IOUK2026 #InterventionalOncology #InterventionalRadiology

A new milestone for innovation in radiotherapy: 𝐭𝐡𝐞 𝐰𝐨𝐫𝐥𝐝’𝐬 𝐟𝐢𝐫𝐬𝐭 𝐨𝐧𝐥𝐢𝐧𝐞 𝐚𝐝𝐚𝐩𝐭𝐢𝐯𝐞 𝐫𝐚𝐝𝐢𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐬𝐞𝐬𝐬𝐢𝐨𝐧 𝐨𝐧 𝐚 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐋𝐢𝐧𝐚𝐜 has been successfully performed at Responsible Research Hospital in Campobasso, enabled by MOZI (Manteia Technologies). This achievement represents a significant step towards increasingly accurate and personalized radiotherapy, allowing treatment adaptation before each fraction, even on conventional treatment machines. As highlighted by Prof. Savino Cilla (HC of Medical Physics Unit), “𝐴𝑑𝑎𝑝𝑡𝑖𝑣𝑒 𝑟𝑎𝑑𝑖𝑜𝑡ℎ𝑒𝑟𝑎𝑝𝑦 𝑝𝑜𝑤𝑒𝑟𝑒𝑑 𝑏𝑦 𝐴𝐼 𝑖𝑠 𝑛𝑜 𝑙𝑜𝑛𝑔𝑒𝑟 𝑗𝑢𝑠𝑡 𝑎 𝑣𝑖𝑠𝑖𝑜𝑛. 𝐼𝑡 𝑖𝑠 𝑏𝑒𝑐𝑜𝑚𝑖𝑛𝑔 𝑎 𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙 𝑟𝑒𝑎𝑙𝑖𝑡𝑦. 𝐼𝑛 𝐶𝑎𝑚𝑝𝑜𝑏𝑎𝑠𝑠𝑜, 𝑀𝑂𝑍𝐼 𝑖𝑠 𝑒𝑛𝑎𝑏𝑙𝑖𝑛𝑔 𝑎𝑑𝑎𝑝𝑡𝑖𝑣𝑒 𝑟𝑎𝑑𝑖𝑜𝑡ℎ𝑒𝑟𝑎𝑝𝑦 𝑡ℎ𝑟𝑜𝑢𝑔ℎ 𝑎𝑟𝑡𝑖𝑓𝑖𝑐𝑖𝑎𝑙 𝑖𝑛𝑡𝑒𝑙𝑙𝑖𝑔𝑒𝑛𝑐𝑒, 𝑠𝑢𝑝𝑝𝑜𝑟𝑡𝑖𝑛𝑔 𝑐𝑙𝑖𝑛𝑖𝑐𝑖𝑎𝑛𝑠 𝑖𝑛 𝑡𝑎𝑖𝑙𝑜𝑟𝑖𝑛𝑔 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑡𝑜 𝑒𝑎𝑐ℎ 𝑝𝑎𝑡𝑖𝑒𝑛𝑡’𝑠 𝑎𝑛𝑎𝑡𝑜𝑚𝑦 𝑜𝑓 𝑡ℎ𝑒 𝑑𝑎𝑦, 𝑒𝑣𝑒𝑟𝑦 𝑠𝑖𝑛𝑔𝑙𝑒 𝑑𝑎𝑦.” Prof. Francesco Deodato (HC of Radiation Oncology Unit) also commented: “𝑊𝑒 𝑎𝑟𝑒 𝑝𝑟𝑜𝑢𝑑 𝑡𝑜 𝑠𝑢𝑝𝑝𝑜𝑟𝑡 𝑡ℎ𝑖𝑠 𝑗𝑜𝑢𝑟𝑛𝑒𝑦 𝑏𝑦 𝑏𝑟𝑖𝑛𝑔𝑖𝑛𝑔 𝑀𝑂𝑍𝐼 𝑖𝑛𝑡𝑜 𝑟𝑒𝑎𝑙 𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙 𝑒𝑛𝑣𝑖𝑟𝑜𝑛𝑚𝑒𝑛𝑡𝑠, 𝑚𝑎𝑘𝑖𝑛𝑔 𝑎𝑑𝑣𝑎𝑛𝑐𝑒𝑑 𝐴𝐼-𝑑𝑟𝑖𝑣𝑒𝑛 𝑝𝑙𝑎𝑛𝑛𝑖𝑛𝑔 𝑎𝑐𝑐𝑒𝑠𝑠𝑖𝑏𝑙𝑒, 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡, 𝑎𝑛𝑑 𝑓𝑢𝑙𝑙𝑦 𝑐𝑜𝑚𝑝𝑎𝑡𝑖𝑏𝑙𝑒 𝑤𝑖𝑡ℎ 𝑒𝑥𝑖𝑠𝑡𝑖𝑛𝑔 𝐿𝑖𝑛𝑎𝑐 𝑤𝑜𝑟𝑘𝑓𝑙𝑜𝑤𝑠.” Because the future of radiation oncology is adaptive — and it is already here! #TemaSinergie #MOZI #AdaptiveRadiotherapy #RadiationOncology #AIinHealthcare

Smarter deployment. Lower impact. Greater accessibility. The latest collaboration between TIC Imaging and Medibence has been designed to support a more sustainable and efficient approach to community-based lung cancer screening. A fully integrated solution means fewer support vehicles, lower fuel consumption, reduced emissions, and quieter operation for local communities, all while delivering quality diagnostic imaging closer to patients. We’re looking forward to unveiling more at UKIO 2026 👀 📍 Liverpool Experience Campus 📅 8–10 June 2026 #LungCancerScreening #MedicalImaging #Radiology #TICImaging #UKIO2026

Boston Scientific has announced a strategic $1.5 billion investment in MiRus LLC, acquiring an approximately 34% equity stake to strengthen its structural heart portfolio and advance next-generation TAVR technologies. The agreement includes an exclusive option to acquire the MiRus TAVR business, including the investigational SIEGEL™ Balloon Expandable Transcatheter Aortic Valve Replacement system designed to improve treatment outcomes for patients with severe aortic stenosis. 🗣️Lance Bates said, “The occurrence and recognition of aortic stenosis is growing rapidly and our investment in MiRus continues our pursuit." 🗣️Jay Yadav MD said, “This collaborative relationship with Boston Scientific alongside the exceptional capabilities of our Atlanta-based team." Read the full article: https://lnkd.in/gqqXqWhk #BostonScientific #MiRus #TAVR #Cardiovascular #MedTech #MedicalInnovation #StructuralHeart #HealthcareInnovation #Biotechnology #MedicalDevices #Cardiology #LifeSciences #HealthcareNews #MedEdgeMEA

When it comes to #patient_immobilization in #radiotherapy, selecting the right brand is paramount for treatment accuracy and patient comfort. I've found that considering the material quality and ergonomic design of immobilization devices significantly impacts their effectiveness. The precision offered by different brands can vary, influencing setup reproducibility and dose delivery. Ultimately, investing in a reputable brand ensures the highest standard of care during #radiotherapy. Klarity Medical thanks so much for being a successful partner with EZMedical during the last couple of Years we are looking forward for more and more successful collaboration. European Society for Radiotherapy and Oncology (ESTRO) #UAE #OMAN #Radiotherapy #PatientCare #MedicalDevices #HealthcareTechnology